194 related articles for article (PubMed ID: 30186230)
1. Succinate as a Regulator of Hepatic Stellate Cells in Liver Fibrosis.
Cho EH
Front Endocrinol (Lausanne); 2018; 9():455. PubMed ID: 30186230
[TBL] [Abstract][Full Text] [Related]
2. Metformin ameliorates activation of hepatic stellate cells and hepatic fibrosis by succinate and GPR91 inhibition.
Nguyen G; Park SY; Le CT; Park WS; Choi DH; Cho EH
Biochem Biophys Res Commun; 2018 Jan; 495(4):2649-2656. PubMed ID: 29278707
[TBL] [Abstract][Full Text] [Related]
3. Succinate causes α-SMA production through GPR91 activation in hepatic stellate cells.
Li YH; Woo SH; Choi DH; Cho EH
Biochem Biophys Res Commun; 2015 Aug; 463(4):853-8. PubMed ID: 26051274
[TBL] [Abstract][Full Text] [Related]
4. Succinate induces hepatic fibrogenesis by promoting activation, proliferation, and migration, and inhibiting apoptosis of hepatic stellate cells.
Park SY; Le CT; Sung KY; Choi DH; Cho EH
Biochem Biophys Res Commun; 2018 Feb; 496(2):673-678. PubMed ID: 29366478
[TBL] [Abstract][Full Text] [Related]
5. LY2405319, an analog of fibroblast growth factor 21 ameliorates α-smooth muscle actin production through inhibition of the succinate-G-protein couple receptor 91 (GPR91) pathway in mice.
Le CT; Nguyen G; Park SY; Choi DH; Cho EH
PLoS One; 2018; 13(2):e0192146. PubMed ID: 29444136
[TBL] [Abstract][Full Text] [Related]
6. Decoding cell death signals in liver inflammation.
Brenner C; Galluzzi L; Kepp O; Kroemer G
J Hepatol; 2013 Sep; 59(3):583-94. PubMed ID: 23567086
[TBL] [Abstract][Full Text] [Related]
7. Succinate: a metabolic signal in inflammation.
Mills E; O'Neill LA
Trends Cell Biol; 2014 May; 24(5):313-20. PubMed ID: 24361092
[TBL] [Abstract][Full Text] [Related]
8. Succinate as a signaling molecule in the mediation of liver diseases.
Chen H; Jin C; Xie L; Wu J
Biochim Biophys Acta Mol Basis Dis; 2024 Feb; 1870(2):166935. PubMed ID: 37976628
[TBL] [Abstract][Full Text] [Related]
9. Insulin resistance promotes Lysyl Oxidase Like 2 induction and fibrosis accumulation in non-alcoholic fatty liver disease.
Dongiovanni P; Meroni M; Baselli GA; Bassani GA; Rametta R; Pietrelli A; Maggioni M; Facciotti F; Trunzo V; Badiali S; Fargion S; Gatti S; Valenti L
Clin Sci (Lond); 2017 Jun; 131(12):1301-1315. PubMed ID: 28468951
[TBL] [Abstract][Full Text] [Related]
10. Wnt signaling in liver fibrosis: progress, challenges and potential directions.
Miao CG; Yang YY; He X; Huang C; Huang Y; Zhang L; Lv XW; Jin Y; Li J
Biochimie; 2013 Dec; 95(12):2326-35. PubMed ID: 24036368
[TBL] [Abstract][Full Text] [Related]
11. Disturbed Vitamin A Metabolism in Non-Alcoholic Fatty Liver Disease (NAFLD).
Saeed A; Dullaart RPF; Schreuder TCMA; Blokzijl H; Faber KN
Nutrients; 2017 Dec; 10(1):. PubMed ID: 29286303
[TBL] [Abstract][Full Text] [Related]
12. Retinoic acids and hepatic stellate cells in liver disease.
Lee YS; Jeong WI
J Gastroenterol Hepatol; 2012 Mar; 27 Suppl 2():75-9. PubMed ID: 22320921
[TBL] [Abstract][Full Text] [Related]
13. Thymosin Beta 4 Is a Potential Regulator of Hepatic Stellate Cells.
Kim J; Jung Y
Vitam Horm; 2016; 102():121-49. PubMed ID: 27450733
[TBL] [Abstract][Full Text] [Related]
14. Lymphotoxin-beta receptor signaling regulates hepatic stellate cell function and wound healing in a murine model of chronic liver injury.
Ruddell RG; Knight B; Tirnitz-Parker JE; Akhurst B; Summerville L; Subramaniam VN; Olynyk JK; Ramm GA
Hepatology; 2009 Jan; 49(1):227-39. PubMed ID: 19111021
[TBL] [Abstract][Full Text] [Related]
15. Hypoxia-inducible factor-1alpha in hepatic fibrosis: A promising therapeutic target.
Zhan L; Huang C; Meng XM; Song Y; Wu XQ; Yang Y; Li J
Biochimie; 2015 Jan; 108():1-7. PubMed ID: 25447141
[TBL] [Abstract][Full Text] [Related]
16. Mitochondrial gene polymorphisms alter hepatic cellular energy metabolism and aggravate diet-induced non-alcoholic steatohepatitis.
Schröder T; Kucharczyk D; Bär F; Pagel R; Derer S; Jendrek ST; Sünderhauf A; Brethack AK; Hirose M; Möller S; Künstner A; Bischof J; Weyers I; Heeren J; Koczan D; Schmid SM; Divanovic S; Giles DA; Adamski J; Fellermann K; Lehnert H; Köhl J; Ibrahim S; Sina C
Mol Metab; 2016 Apr; 5(4):283-295. PubMed ID: 27069868
[TBL] [Abstract][Full Text] [Related]
17. Protease-activated receptor 2 promotes experimental liver fibrosis in mice and activates human hepatic stellate cells.
Knight V; Tchongue J; Lourensz D; Tipping P; Sievert W
Hepatology; 2012 Mar; 55(3):879-87. PubMed ID: 22095855
[TBL] [Abstract][Full Text] [Related]
18. Interaction of hepatic stellate cells with diverse types of immune cells: foe or friend?
Yi HS; Jeong WI
J Gastroenterol Hepatol; 2013 Aug; 28 Suppl 1():99-104. PubMed ID: 23855303
[TBL] [Abstract][Full Text] [Related]
19. IGF-I induces senescence of hepatic stellate cells and limits fibrosis in a p53-dependent manner.
Nishizawa H; Iguchi G; Fukuoka H; Takahashi M; Suda K; Bando H; Matsumoto R; Yoshida K; Odake Y; Ogawa W; Takahashi Y
Sci Rep; 2016 Oct; 6():34605. PubMed ID: 27721459
[TBL] [Abstract][Full Text] [Related]
20. p62/SQSTM1 by Binding to Vitamin D Receptor Inhibits Hepatic Stellate Cell Activity, Fibrosis, and Liver Cancer.
Duran A; Hernandez ED; Reina-Campos M; Castilla EA; Subramaniam S; Raghunandan S; Roberts LR; Kisseleva T; Karin M; Diaz-Meco MT; Moscat J
Cancer Cell; 2016 Oct; 30(4):595-609. PubMed ID: 27728806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
